Continuous Infusion of Recombinant Factor VIIa (NovoSeven®) in the Treatment of a Patient with Type III von Willebrand’s Disease and Alloantibodies against von Willebrand Factor - Grossmann, R.E.; Geisen, U.; Schwender, S.; Keller, F. (Thrombosis and Haemostasis, 2000)